Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments

Staskin, David

doi:10.1080/14656566.2022.2117609

Expert Opinion on Pharmacotherapy

2022

DOI: 10.1080/14656566.2022.2117609

|View full text |Cite

Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments

David Staskin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Like mirabegron, vibegron can increase digoxin concentrations. 9 Looking back at our data, this interaction could have been relevant for one patient if a β 3 -adrenergic agonist was started.…”

mentioning

confidence: 85%

Reply to: Commentary on: Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly

Bankes¹,

Turgeon²

2022

J American Geriatrics Society

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 85%

Reply to: Commentary on: Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly

Bankes¹,

Turgeon²

2022

J American Geriatrics Society

View full text Add to dashboard Cite

show abstract

A historical perspective on anticholinergics in overactive bladder (OAB) treatment: “Foundations, current practices, and future prospects”

Ochoa,

Bouchard,

Abrams

2024

Continence

View full text Add to dashboard Cite

Bridging present and future: A narrative review and visionary outlook on innovative solutions for the diagnosis and treatment of urinary incontinence

Rotem,

Weintruab,

Padoa

2024

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments

Cited by 3 publications

References 13 publications

Reply to: Commentary on: Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly

Reply to: Commentary on: Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly

A historical perspective on anticholinergics in overactive bladder (OAB) treatment: “Foundations, current practices, and future prospects”

Bridging present and future: A narrative review and visionary outlook on innovative solutions for the diagnosis and treatment of urinary incontinence

Contact Info

Product

Resources

About